{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 1846232}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 669000, "exercisedValue": 0, "unexercisedValue": 3188312}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 104423, "exercisedValue": 0, "unexercisedValue": 55346}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nandan  Oza B.S.", "age": 62, "title": "Head of Chemistry, Manufacturing & Control", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Bauer", "title": "Head of Cell Therapy Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.68, "open": 1.69, "dayLow": 1.56, "dayHigh": 1.71, "regularMarketPreviousClose": 1.68, "regularMarketOpen": 1.69, "regularMarketDayLow": 1.56, "regularMarketDayHigh": 1.71, "payoutRatio": 0.0, "beta": 0.253, "forwardPE": -2.9272728, "volume": 49335, "regularMarketVolume": 49335, "averageVolume": 68318, "averageVolume10days": 49930, "averageDailyVolume10Day": 49930, "bid": 1.56, "ask": 1.65, "bidSize": 1, "askSize": 1, "marketCap": 44632580, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 3.13, "fiftyDayAverage": 1.82286, "twoHundredDayAverage": 1.918295, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 28025410, "profitMargins": 0.0, "floatShares": 17986658, "sharesOutstanding": 27722100, "sharesShort": 367356, "sharesShortPriorMonth": 389439, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0134000005, "heldPercentInsiders": 0.39786997, "heldPercentInstitutions": 0.12101, "shortRatio": 6.52, "shortPercentOfFloat": 0.0425, "impliedSharesOutstanding": 27722100, "bookValue": 0.481, "priceToBook": 3.3471932, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -21613376, "trailingEps": -0.76, "forwardEps": -0.55, "enterpriseToEbitda": -1.238, "52WeekChange": -0.4738562, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.61, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 17681954, "totalCashPerShare": 0.638, "ebitda": -22641740, "totalDebt": 1074770, "quickRatio": 2.263, "currentRatio": 2.325, "debtToEquity": 8.111, "returnOnAssets": -0.66110003, "returnOnEquity": -1.47334, "freeCashflow": -7551199, "operatingCashflow": -14595102, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.1666627, "regularMarketPrice": 1.61, "cryptoTradeable": false, "marketState": "PRE", "regularMarketChange": -0.06999993, "regularMarketDayRange": "1.56 - 1.71", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 68318, "fiftyTwoWeekLowChange": 0.35000002, "fiftyTwoWeekLowChangePercent": 0.2777778, "fiftyTwoWeekRange": "1.26 - 3.13", "fiftyTwoWeekHighChange": -1.5200001, "fiftyTwoWeekHighChangePercent": -0.48562303, "fiftyTwoWeekChangePercent": -47.38562, "earningsTimestamp": 1742846400, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.76, "epsForward": -0.55, "epsCurrentYear": -0.7161, "priceEpsCurrentYear": -2.2482893, "fiftyDayAverageChange": -0.21285999, "fiftyDayAverageChangePercent": -0.11677254, "twoHundredDayAverageChange": -0.308295, "twoHundredDayAverageChangePercent": -0.16071303, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "displayName": "Immix Biopharma", "trailingPegRatio": null}